fluoxetine has been researched along with phentermine in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (24.00) | 18.2507 |
2000's | 14 (56.00) | 29.6817 |
2010's | 5 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bostwick, JM; Brown, TM | 1 |
Njo, L; Rich, JM; Roberts, KW; Smith, KP | 1 |
Borrell, L; Foreyt, JP; Haddock, CK; Poston, WS | 1 |
Archer, SL; Nelson, DP; Reeve, HL; Weir, EK | 1 |
Cowley, G; Springen, K | 1 |
Marshall, M; Roth, JD; Rowland, NE | 1 |
Carino, JS; Devlin, MJ; Goldfein, JA; Wolk, SL | 1 |
Callahan, BT; Ricaurte, GA; Yuan, J | 1 |
Lo, J; Robertson, K; Rowland, NE | 1 |
Aspley, S; Auerbach, S; Brammer, R; Fray, A; Heal, D; Tao, R | 1 |
Jones, SL; Miller, DK; Wellman, PJ | 1 |
Dunlop, PC; Johnson, GJ; Leis, LA; Weir, EK | 1 |
Li, Z; Maggard, M; Maglione, M; Mojica, WA; Morton, SC; Shekelle, PG; Shugarman, L; Solomon, V; Suttorp, M; Tu, W | 1 |
Arterburn, D | 2 |
Arterburn, D; DeLaet, D; Flum, D | 1 |
Baumann, MH; Rothman, RB; Zolkowska, D | 1 |
Atkinson, RL; Dhurandhar, NV; Rahko, PS; Whigham, LD | 1 |
6 review(s) available for fluoxetine and phentermine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Challenges in obesity management.
Topics: 1-Naphthylamine; Adrenergic beta-Agonists; Appetite Depressants; Behavior Therapy; Caffeine; Cyclobutanes; Diethylpropion; Ephedrine; Fenfluramine; Fluoxetine; Humans; Lactones; Leptin; Lipase; Obesity; Orlistat; Phentermine; Proteins; Sertraline | 1998 |
Pharmacological and surgical treatment of obesity.
Topics: Adult; Appetite Depressants; Bupropion; Cyclobutanes; Diethylpropion; Fluoxetine; Fructose; Gastric Bypass; Gastroplasty; Humans; Lactones; Lipase; Obesity; Orlistat; Phentermine; Topiramate | 2004 |
Obesity.
Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine; Phenylpropanolamine | 2003 |
Obesity.
Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine; Phenylpropanolamine; Selective Serotonin Reuptake Inhibitors | 2004 |
Obesity.
Topics: Adult; Appetite Depressants; Cyclobutanes; Diethylpropion; Fluoxetine; Gastric Bypass; Gastroplasty; Humans; Lactones; Mazindol; Obesity; Orlistat; Phentermine | 2005 |
1 trial(s) available for fluoxetine and phentermine
Article | Year |
---|---|
Open treatment of overweight binge eaters with phentermine and fluoxetine as an adjunct to cognitive-behavioral therapy.
Topics: Adult; Appetite Depressants; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Hyperphagia; Middle Aged; Obesity; Phentermine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2000 |
18 other study(ies) available for fluoxetine and phentermine
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Fluoxetine (Prozac) and other drugs for treatment of obesity.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Fenfluramine; Fluoxetine; Humans; Obesity; Phentermine | 1994 |
A toxic reaction from combining fluoxetine and phentermine.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Appetite Depressants; Arousal; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Phentermine | 1996 |
Unusual hypotension and bradycardia in a patient receiving fenfluramine, phentermine, and fluoxetine.
Topics: Anesthesia, Conduction; Anesthetics, Intravenous; Appetite Depressants; Bradycardia; Drug Interactions; Fenfluramine; Fentanyl; Fluoxetine; Humans; Hypotension; Intraoperative Complications; Male; Middle Aged; Phentermine; Selective Serotonin Reuptake Inhibitors; Sympathomimetics | 1998 |
Effects of fluoxetine, phentermine, and venlafaxine on pulmonary arterial pressure and electrophysiology.
Topics: Animals; Blood Pressure; Cyclohexanols; Electric Conductivity; Electrophysiology; Fluoxetine; In Vitro Techniques; Male; Membrane Potentials; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Phentermine; Potassium Channel Blockers; Potassium Channels; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
After fen-phen.
Topics: Antidepressive Agents, Second-Generation; Appetite Depressants; Consumer Product Safety; Fenfluramine; Fluoxetine; Heart Valve Diseases; Humans; Obesity; Phentermine; Risk Factors; United States; Weight Loss | 1997 |
Comparison of either norepinephrine-uptake inhibitors or phentermine combined with serotonergic agents on food intake in rats.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Desipramine; Dexfenfluramine; Dose-Response Relationship, Drug; Drug Synergism; Eating; Female; Fluoxetine; Norepinephrine; Phentermine; Piperazines; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Receptor Agonists; Time Factors | 2000 |
Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine.
Topics: Animals; Anorexia; Appetite Depressants; Biogenic Monoamines; Body Temperature; Body Weight; Brain; Dopamine Antagonists; Eating; Fluoxetine; Liver; Male; Mice; Oxidoreductases; Phentermine; Time Factors | 2000 |
Acute anorectic effect of single and combined drugs in mice using a non-deprivation protocol.
Topics: Animals; Appetite Depressants; Dexfenfluramine; Drug Combinations; Eating; Female; Fluoxetine; Food Deprivation; Mice; Mice, Inbred C57BL; Phentermine; Serotonin Receptor Agonists | 2001 |
Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine.
Topics: Aminorex; Animals; Drug Combinations; Fenfluramine; Fluoxetine; Hypothalamus; Male; Phentermine; Rats; Rats, Sprague-Dawley; Serotonin | 2002 |
Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Appetite Depressants; Body Weight; Cyclobutanes; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Eating; Fenfluramine; Fluoxetine; Male; Norepinephrine; Phentermine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2003 |
The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
Topics: Appetite Depressants; Blood Platelets; Dose-Response Relationship, Drug; Fenfluramine; Fluoxetine; Humans; Hydrogen-Ion Concentration; Norfenfluramine; Phentermine; Reserpine; Secretory Vesicles; Selective Serotonin Reuptake Inhibitors; Serotonin | 2003 |
Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease.
Topics: Amphetamines; Animals; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Electrochemistry; Fluoxetine; Heart Diseases; Hydroxyindoleacetic Acid; Indicators and Reagents; Lung Diseases; Male; Methamphetamine; Microdialysis; Mitogens; Muscle, Smooth, Vascular; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stimulation, Chemical | 2006 |
Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.
Topics: Adult; Appetite Depressants; Body Mass Index; Drug Therapy, Combination; Fenfluramine; Fluoxetine; Heart Valve Diseases; Humans; Medical Records; Obesity; Phentermine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Ultrasonography; Weight Loss | 2007 |